US Patent 12122841 Human CGRP receptor binding proteins
Patent 12122841 was granted and assigned to Amgen on October, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+40 properties)
Article (+392 characters)
US Patent 12122841 Human CGRP receptor binding proteins
Article
Patent abstract
Antigen binding proteins that bind to human CGRP receptor (CGRP R) are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of CGRP R to CGRP, and are useful in a number of CGRP R related disorders, including the treatment and/or prevention of migraine headaches.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Cen Xu0
Chadwick T. King0
Colin V. Gegg, Jr.0
David W. Brankow0
Hsieng Sen Lu0
Licheng Shi0
Shaw-Fen Sylvia Hu0
Thomas C. Boone0
Date of Patent
October 22, 2024
0Patent Application Number
171114420
Date Filed
December 3, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12122841 Human CGRP receptor binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
